PHOTO
UAE: Studies suggest that one in 10 women live with Adenomyosis, a condition in the reproductive system that can cause pelvic pain and irregular bleeding, and yet not many women are aware of such a condition. What is it and why should women especially the ones planning to conceive should care?
Dr. Laura Melado, IVI Middle East Fertility Clinic, explained that Adenomyosis is a growth of endometrial tissue into the walls of the uterus. Previously classified as a form of Endometriosis, it exhibits symptoms similar to those experienced by women with fibroids. Some, however, do not report any symptoms at all.
“Traditionally, this medical issue is discovered only after the examination of a tissue from a uterus that has been removed surgically. The process of removing the uterus is known as Hysterectomy. However, experts are looking at more practical procedures, including MRI and 3D ultrasound, to diagnose the condition faster and without the patient going through the highly invasive operation. If diagnosed, a patient is normally prescribed with anti-inflammatory drugs and hormone medications, among others,” said Dr Laura. She also added further:
“Does adenomyosis affect a woman’s chances of getting pregnant? This has been one of the most common questions and the answer is: yes, it has been found to cause infertility. For females undergoing In-vitro Fertilisation (IVF) procedure, in particular, studies show reduced chances of successful embryo implantation and increased miscarriage rate.”
More research, said Dr Laura, is needed to put in place more effective protocols in handling cases of women with adenomyosis who are set to undergo IVF. IVI Fertility Middle East manages state-of-the-art clinics in Abu Dhabi and Dubai in the UAE and Muscat in Oman. IVI Fertility offers highly personalised and cost-effective treatments for both male and female infertility conditions and is backed by the most advanced technologies in the field. The institution delivers the highest success rate of over 70% in the region and is the preferred choice for couples who have unexplained infertility or previously failed IVF cycles.
© Press Release 2020Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
